epigallocatechin gallate has been researched along with Demyelinating Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azarnia, M; Mashayekhi, F; Salehi, Z; Semnani, M | 1 |
| Meydani, SN; Ren, Z; Wang, J; Wu, D; Xiao, S; Xu, Y | 1 |
2 other study(ies) available for epigallocatechin gallate and Demyelinating Diseases
| Article | Year |
|---|---|
Effects of green tea epigallocatechin-3-gallate on the proteolipid protein and oligodendrocyte transcription factor 1 messenger RNA gene expression in a mouse model of multiple sclerosis.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Brain; Catechin; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Mice, Inbred C57BL; Multiple Sclerosis; Oligodendroglia; RNA, Messenger; Tea | 2017 |
Epigallocatechin-3-gallate ameliorates experimental autoimmune encephalomyelitis by altering balance among CD4+ T-cell subsets.
Topics: Animals; Catechin; CD4-Positive T-Lymphocytes; Cell Proliferation; Cytokines; Demyelinating Diseases; Dietary Supplements; Down-Regulation; Encephalomyelitis, Autoimmune, Experimental; Female; Mice; Mice, Inbred C57BL; Monocytes; Multiple Sclerosis; Myelin Proteins; Myelin-Oligodendrocyte Glycoprotein; Neuritis; Neuroprotective Agents; Nuclear Receptor Subfamily 1, Group F, Member 3; Random Allocation; T-Box Domain Proteins; T-Lymphocyte Subsets | 2012 |